Acasti Pharma Inc. (NASDAQ:ACST Get Free Report) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 6,600 shares, a...
Acasti Pharma Inc. (NASDAQ:ACST Get Free Report) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.56...
Acasti Pharma Inc. (NASDAQ:ACST Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 29th, there was short interest totalling...
Acasti Pharma Inc. (NASDAQ:ACST Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.38...
Acasti Pharma Inc. (NASDAQ:ACST Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling...
Acasti Pharma (NASDAQ:ACST Get Free Report) announced its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) earnings per share (EPS) for the quarter...
Projected Cash Runway Extends into Second Calendar Quarter 2026, Well Beyond Potential 1H 2025 Submission of GTX-104 New Drug Application (NDA)Patient Enrollment in Pivotal STRIVE-ON Phase 3 Trial...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...